Imiquimod

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5862 publications

Two-dimensional GeTe nanosheets for psoriasis through modulation of macrophage activation and psoriatic inflammation.

Two-dimensional GeTe nanosheets for psoriasis through modulation of macrophage activation and psoriatic inflammation.

Journal: Biomaterials science

Published: May 26, 2026

Skin Cancer: Management of Actinic Keratoses and Keratinocyte Carcinomas.

Skin Cancer: Management of Actinic Keratoses and Keratinocyte Carcinomas.

Journal: FP essentials

Published: May 21, 2026

Imiquimod for Melanoma in Situ and Lentigo Maligna: A Systematic Review.

Imiquimod for Melanoma in Situ and Lentigo Maligna: A Systematic Review.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: May 20, 2026

Treatment of Nodular Basal Cell Carcinoma With Topical 5% Imiquimod Cream: An Autobiographical Case Report.

Treatment of Nodular Basal Cell Carcinoma With Topical 5% Imiquimod Cream: An Autobiographical Case Report.

Journal: Cureus

Published: May 14, 2026

Updates on Chromoblastomycosis: Evolving Insights in Clinical Management and Therapeutic Strategies.

Updates on Chromoblastomycosis: Evolving Insights in Clinical Management and Therapeutic Strategies.

Journal: Current fungal infection reports

Published: May 08, 2026

Basal Medium Affects the Biological Characteristics and Immunomodulatory Functions of MSCs.

Basal Medium Affects the Biological Characteristics and Immunomodulatory Functions of MSCs.

Journal: Applied biochemistry and biotechnology

Published: May 02, 2026

Ruxolitinib phosphate-laden nanoemulgel: amelioration of ex vivo permeation and in vivo therapeutic efficacy for the effective therapeutic management of psoriasis.

Ruxolitinib phosphate-laden nanoemulgel: amelioration of ex vivo permeation and in vivo therapeutic efficacy for the effective therapeutic management of psoriasis.

Journal: Inflammopharmacology

Published: May 01, 2026

Four-week neoadjuvant 5% imiquimod prior to Mohs micrographic surgery for melanoma in situ: A prospective pilot study.

Four-week neoadjuvant 5% imiquimod prior to Mohs micrographic surgery for melanoma in situ: A prospective pilot study.

Journal: JAAD international

Published: April 30, 2026

Keratinocyte-specific STAT3 knockout attenuates imiquimod-induced psoriasiform phenotype in mice.

Keratinocyte-specific STAT3 knockout attenuates imiquimod-induced psoriasiform phenotype in mice.

Journal: Experimental animals

Published: April 29, 2026

Polymannose-Guided Repolarization of Tumor-Associated Macrophages for Enhanced Photodynamic Immunotherapy.

Polymannose-Guided Repolarization of Tumor-Associated Macrophages for Enhanced Photodynamic Immunotherapy.

Journal: ACS macro letters

Published: April 28, 2026

3D-Printed lesion-conformal light-guiding patches for precise and personalized psoriasis phototherapy.

3D-Printed lesion-conformal light-guiding patches for precise and personalized psoriasis phototherapy.

Journal: Biomaterials science

Published: April 24, 2026

Secoisolariciresinol diglucoside resolves systemic and skin inflammation in psoriatic mice by ameliorating the gut microbiome and modulating immune responses.

Secoisolariciresinol diglucoside resolves systemic and skin inflammation in psoriatic mice by ameliorating the gut microbiome and modulating immune responses.

Journal: Food & function

Published: April 21, 2026

Showing 1-12 of 5,862

Last Updated: 06/30/2026